Infection related late mortality in survivors of childhood cancer with asplenia or radiation-induced hyposplenism: A report from the Childhood Cancer Survivor Study.

Authors

null

Brent Weil

Boston Children's Hospital, Boston, MA

Brent Weil , Arin L Madenci , Qi Liu , Todd M. Gibson , Yutaka Yasui , Joseph Philip Neglia , Wendy M. Leisenring , Rebecca M. Howell , Emily S. Tonorezos , Danielle Novetsky Friedman , Christopher Tinkle , Lisa Diller , Gregory T. Armstrong , Kevin C. Oeffinger , Christopher Bertero Weldon

Organizations

Boston Children's Hospital, Boston, MA, University of Alberta, Edmonton, AB, Canada, St. Jude Children's Research Hospital, Memphis, TN, University of Minnesota, Minneapolis, MN, Fred Hutchinson Cancer Research Center, Seattle, WA, The University of Texas MD Anderson Cancer Center, Houston, TX, Memorial Sloan-Kettering Cancer Center, New York, NY, Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA

Research Funding

NIH

Background: Asplenia or hyposplenism can develop in survivors of childhood cancer following splenectomy or radiotherapy exposure to the left upper quadrant of the abdomen (LUQ). Knowledge regarding long-term infection related outcomes for these survivors is limited. Methods: Infection related late mortality (sepsis, meningitis or pneumonia) was evaluated in 20,805 5-year survivors (diagnosed <21 years of age from 1970-1999, median follow-up 26 years, range 5-44) using cumulative incidence and Poisson regression models to calculate adjusted relative risk (RR) and 95% confidence intervals (CI). Average LUQ radiation was calculated as a surrogate for splenic radiation. Results: Treatment included splenectomy for 1328 survivors (6%). An additional 10,295 (49%) were exposed to LUQ radiotherapy without splenectomy. The cumulative incidence of infection related late mortality was 1.4% (95%CI: 0.7%-2.2%) at 35 years after splenectomy and 0.6% (95%CI: 0.4%-0.8%) after LUQ radiotherapy, with a total of 78 deaths attributable to infectious causes (25 sepsis, 1 meningitis, 52 pneumonia). Splenectomy (RR=8.4, p<0.001) and increasing LUQ radiotherapy dose (p<0.001) were independently associated with infection related late mortality (Table). Conclusions: Splenectomy and LUQ radiotherapy increased risk for infection related late mortality. While infectious mortality increased with increasing LUQ radiation dose, even lower dose exposure (<10Gy) increased risk substantially. Accordingly, cancer survivors exposed to LUQ radiotherapy should be considered at risk for functional asplenia and managed similarly to asplenic individuals with respect to vaccinations and febrile illnesses.

Multivariate analysis of factors associated with infection related late mortality.*

TreatmentRR (95% CI)P
No splenectomy; no RT (Ref.)1.0
Splenectomy8.4 (3.5 - 20.1)<0.001
No splenectomy, 0.1-10 Gy LUQ RT2.4 (1.1 - 5.2)0.028
No splenectomy, 10-19 Gy LUQ RT6.1 (2.5 – 14.9)<0.001
No splenectomy, 20+ Gy LUQ RT9.3 (3.2 – 27.0)<0.001

*Adjusted for age at diagnosis, attained age, sex, race and chronic health conditions. RT, radiotherapy.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Survivorship

Citation

J Clin Oncol 35, 2017 (suppl; abstr 10563)

DOI

10.1200/JCO.2017.35.15_suppl.10563

Abstract #

10563

Poster Bd #

320

Abstract Disclosures